Multiple effects of pepstatin A on Trypanosoma cruzi epimastigote forms

Parasitology Research

Volumn 110, Issue 6, 2012, Pages 2533-2540

  Sangenito, Leandro S ^a   Gonçalves, Keyla C ^a   Abi chacra, Érika A ^a   Sodré, Cátia L ^a   D'Avila Levy, Claudia M ^b   Branquinha, Marta H ^a   Santos, André L S ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC PROTEINASE; CALPAIN; CATHEPSIN D; CRUZIPAIN; GLYCOPROTEIN; PEPSTATIN; PROTEIN GP63; UNCLASSIFIED DRUG;

ANTIPROLIFERATIVE ACTIVITY; ANTIPROTOZOAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOLYSIS; DOSE TIME EFFECT RELATION; DRUG DETERMINATION; DRUG EFFECT; EPIMASTIGOTE; FLAGELLUM; GROWTH INHIBITION; HYDROLYSIS; IC 50; NONHUMAN; PARASITE EXAMINATION; PHYLOGENY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SPECIES DIFFERENTIATION; STRAIN DIFFERENCE; STRUCTURE ANALYSIS; TRYPANOSOMA CRUZI; TRYPOMASTIGOTE; UPREGULATION;

ANIMALS; ANTIPROTOZOAL AGENTS; FLAGELLA; HUMANS; INHIBITORY CONCENTRATION 50; MICROSCOPY; PARASITIC SENSITIVITY TESTS; PEPSTATINS; TRYPANOSOMA CRUZI;

TRYPANOSOMA CRUZI;

EID: 84863437250     PISSN: 09320113     EISSN: 14321955     Source Type: Journal    
DOI: 10.1007/s00436-011-2796-3     Document Type: Article

References (42)

1. Alves CR, Corte-Real S, Bourguignon SC, Chaves CS, Saraiva EMB (2005) Leishmania amazonensis: early proteinase activities during promastigote- amastigote differentiation in vitro. Exp Parasitol 112:63-65
2. Andrade SG (1999) Trypanosoma cruzi: clonal structure of parasite strains and the importance of principal clones. Mem Inst Oswaldo Cruz 94:185-187 (Pubitemid 129584492)
3. Bastos IM, Grellier P, Martins NF, Cadavid-Restrepo G, de Souza-Ault MR, Augustyns K, Teixeira AR, Schréve J, Maigret B, da Silveira JF, Santana JM (2005) Molecular, functional and structural properties of the prolyl oligopeptidase of Trypanosoma cruzi (POP Tc80), which is required for parasite entry into mammalian cells. Biochem J 388:29-38 (Pubitemid 40732929)
4. Bisaggio DF, Campanati L, Pinto RC, Souto-Padrón T (2006) Effect of suramin on trypomastigote forms of Trypanosoma cruzi: changes on cell motility and on the ultrastructure of the flagellum-cell body attachment region. Acta Trop 98:162-175 (Pubitemid 44208723)
5. Bisaggio DF, Adade CM, Souto-Padrón T (2008) In vitro effects of suramin on Trypanosoma cruzi. Int J Antimicrob Agents 31:282-286
6. Cardoso J, Soares MJ, Menna-Barreto RF, Le Bloas R, Sotomaior V, Goldenberg S, Krieger MA (2008) Inhibition of proteasome activity blocks Trypanosoma cruzi growth and metacyclogenesis. Parasitol Res 103:941-951
7. Castillo E, Dea-Ayuela MA, Bolás-Fernández F, Rangel M, González-Rosende ME (2010) The kinetoplastid chemotherapy revisited: current drugs, recent advances and future perspectives. Curr Med Chem 17:4027-4051
8. Cazzulo JJ (2002) Proteinases of Trypanosoma cruzi: patential targets for the chemotherapy of Chagas disease. Curr Top Med Chem 2:1261-1271
9. Cazzulo JJ, Stoka V, Turk V (2001) The major cysteine proteinase of Trypanosoma cruzi: a valid target for chemotherapy of Chagas disease. Curr Pharm Des 7:1143-1156 (Pubitemid 32640574)
10. d'Avila-Levy CM, Marinho FA, Santos LO, Martins JL, Santos ALS, Branquinha MH (2006) Antileishmanial activity of MDL 28170, a potent calpain inhibitor. Int J Antimicrob Agents 28:138-142 (Pubitemid 44164364)
11. Dost CK, Saraiva J, Monesi N, Zentgraf U, Engels W, Albuquerque S (2004) Six Trypanosoma cruzi strains characterized by specific gene expression patterns. Parasitol Res 94:134-140 (Pubitemid 39371733)
12. Eder J, Hommel U, Cumin F, Martoglio B, Gerhartz B (2007) Aspartic proteases in drug discovery. Curr Pharm Des 13:271-285 (Pubitemid 46085279)
13. Ennes-Vidal V, Menna-Barreto RF, Santos ALS, Branquinha MH, d'Avila-Levy CM (2010) Effects of the calpain inhibitor MDL28170 on the clinically relevant forms of Trypanosoma cruzi in vitro. J Antimicrob Chemother 65:1395-1398
14. Ennes-Vidal V, Menna-Barreto RF, Santos ALS, Branquinha MH, d'Avila-Levy CM (2011) MDL28170, a calpain inhibitor, affects Trypanosoma cruzi metacyclogenesis, ultrastructure and attachment to Rhodnius prolixus midgut. PLoS One 6: e18371
15. Fampa P, Lisboa CV, Jansen AM, Santos ALS, Ramirez MI (2008) Protease expression analysis in recently field-isolated strains of Trypanosoma cruzi: a heterogeneous profile of cysteine protease activities between TC I and TC II major phylogenetic groups. Parasitology 135:1093-1100
16. Fampa P, Santos ALS, Ramirez MI (2010) Trypanosoma cruzi: ubiquity expression of surface cruzipain molecules in TCI and TCII field isolates. Parasitol Res 107:443-447
17. Figueiredo RC, Rosa DS, Soares MJ (2000) Differentiation of Trypanosoma cruzi epimastigotes: metacyclogenesis and adhesion to substrate are triggered by nutritional stress. J Parasitol 86:1213-1218 (Pubitemid 32047189)
18. Gomes SA, Misael D, Silva BA, Feder D, Silva CS, Gonçalves TC, Santos ALS, Santos-Mallet JR (2009) Major cysteine protease (cruzipain) in Z3 sylvatic isolates of Trypanosoma cruzi from Rio de Janeiro, Brazil. Parasitol Res 105:743-749
19. Kikuchi SA, Sodré CL, Kalume DE, Elias CGR, Santos ALS, de Nazaré SM, Meuser M, Chapeaurouge A, Perales J, Fernandes O (2010) Proteomic analysis of two Trypanosoma cruzi zymodeme 3 strains. Exp Parasitol 126:540-551
20. Kumar P, Lodge R, Trudel N, Ouellet M, Ouellette M, Tremblay MJ (2010) Nelfinavir, an HIV-1 protease inhibitor, induces oxidative stress-mediated, caspase-independent apoptosis in Leishmania amastigotes. PLoS Negl Trop Dis 4:e642
21. Landfear SM, Ignatushchenko M (2001) The flagellum and flagellar pocket of trypanosomatids. Mol Biochem Parasitol 115:1-17 (Pubitemid 32493848)
22. Ma L, Chen K, Meng Q, Liu Q, Tang P, Hu S, Yu J (2011) An evolutionary analysis of trypanosomatid GP63 proteases. Parasitol Res 109:1075-1084
23. Mathieu-Daudé F, Bosseno MF, Garzon E, Lelièvre J, Sereno D, Ouaissi A, Brenière SF (2007) Sequence diversity and differential expression of Tc52 immuno-regulatory protein in Trypanosoma cruzi: potential implications in the biological variability of strains. Parasitol Res 101:1355-1363 (Pubitemid 47389448)
24. Miles M (2003) American trypanosomiasis (Chagas disease). In: Cook G, Zumula A (eds) Manson tropical disease. Elsevier Science, London, pp 1325-1337
25. Pinho RT, Beltramini LM, Alves CR, de Simone SG (2009) Trypanosoma cruzi: isolation and characterization of aspartyl proteases. Exp Parasitol 122:128-133
26. Rassi A Jr, Rassi A, Marin-Neto JA (2010) Chagas disease. Lancet 375:1388-1402
27. Rawlings N, Barrett AJ (1995) Families of aspartic peptidases and those of unknown catalytic mechanism. Methods Enzymol 248:105-120
28. Sánchez-Sancho F, Campillo NE, Páez JA (2010) Chagas disease: progress and new perspectives. Curr Med Chem 17:423-452
29. Sangenito LS, Ennes-Vidal V, Marinho FA, Da Mota FF, Santos ALS, d'Avila-Levy CM, Branquinha MH (2009) Arrested growth of Trypanosoma cruzi by the calpain inhibitor MDL28170 and detection of calpain homologues in epimastigote forms. Parasitology 136:433-441
30. Santos ALS, d'Avila-Levy CM, Dias FA, Ribeiro RO, Pereira FM, Elias CGR, Souto-Padrón T, Lopes AHCS, Alviano CS, Branquinha MH, Soares RMA (2006) Phytomonas serpens: cysteine peptidase inhibitors interfere with growth, ultrastructure and host adhesion. Int J Parasitol 36:47-56 (Pubitemid 43049696)
31. Santos LO, Marinho FA, Altoé EF, Vitório BS, Alves CR, Britto C, Motta MC, Branquinha MH, Santos ALS, d'Avila-Levy CM (2009) HIV aspartyl peptidase inhibitors interfere with cellular proliferation, ultrastructure and macrophage infection of Leishmania amazonensis. PLoS One 4:e4918
32. Santos-Mallet JR, Silva CS, Gomes SA, Oliveira DL, Santos CL, Sousa DM, Pinheiro NL, Junqueira AC, Gonçalves TC (2008) Molecular characterization of Trypanosoma cruzi sylvatic isolates from Rio de Janeiro, Brazil. Parasitol Res 103:1041-1045
33. Savoia D, Allice T, Tovo PA (2005) Antileishmanial activity of HIV protease inhibitors. Int J Antimicrob Agents 26:92-94 (Pubitemid 40854125)
34. Soares MJ, Souto-Padrón T, Bonaldo MC, Goldenberg S, de Souza W (1989) A stereological study of the differentiation process in Trypanosoma cruzi. Parasitol Res 75:522-527 (Pubitemid 19180287)
35. Takahashi K (1994) Aspartic proteinases: structure, function, biology and biomedical implications. Adv Exp Med Biol 362:101-110
36. Troeberg L, Morty RE, Pike RN, Lonsdale-Eccles JD, Palmer JT, McKerrow JH, Coetzer THT (1999) Cysteine proteinase inhibitors kill cultured bloodstream forms of Trypanosoma brucei brucei. Exp Parasitol 91:349-355 (Pubitemid 29372440)
37. Trudel N, Garg R, Messier N, Sundar S, Ouellette M, Tremblay MJ (2008) Intracellular survival of Leishmania species that cause visceral leishmaniasis is significantly reduced by HIV-1 protease inhibitors. J Infect Dis 198:1292-1299
38. Valdivieso E, Dagger F, Rascón A (2007) Leishmania mexicana: identification and characterization of an aspartyl proteinase activity. Exp Parasitol 116:77-82 (Pubitemid 46412309)
39. Valdivieso E, Rangel A, Moreno J, Saugar JM, Cañavate C, Alvar J, Dagger F (2010) Effects of HIV aspartyl-proteinase inhibitors on Leishmania sp. Exp Parasitol 126:557-563
40. Venegas J, Miranda S, Coñoepan W, Pîchuantes S, Jercic MI, González C, Gajardo M, Apt W, Arribada A, Sánchez G (2010) Microsatellite marker analysis shows differentiation among Trypanosoma cruzi populations of peripheral blood and dejections of Triatoma infestans fed on the same chronic chagasic patients: microsatellite marker analysis and T. cruzi. Parasitol Res 107:855-863
41. Yao C (2010) Major surface protease of trypanosomatids: one size fits all? Infect Immun 78:22-31
42. Zingales B, Andrade SG, Briones MR, Campbell DA, Chiari E, Fernandes O, Guhl F, Lages-Silva E, Macedo AM, Machado CR, Miles MA, Romanha AJ, Sturm NR, Tibayrenc M, Schijman AG (2009) A new consensus for Trypanosoma cruzi intraspecific nomenclature: second revision meeting recommends TcI to TcVI. Mem Inst Oswaldo Cruz 104:1051-1054